#scleroderma
God damn Scleroderma.
November 14, 2026 at 5:48 PM
Morphea is a rare inflammatory skin condition, also called localized scleroderma, that causes patches of skin and the tissue beneath to thicken and harden from excess collagen.

Learn more: https://scleroderma.org/

You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness
November 15, 2026 at 3:44 PM
According to Google, via Lens

• Species: It appears to be an earthball (genus Scleroderma), most likely the Common Earthball (Scleroderma citrinum).

• Poisonous: The Common Earthball is poisonous and considered inedible. Consuming it can cause severe gastrointestinal upset, nausea, and vomiting.
November 7, 2026 at 5:33 PM
Lupus and Rheumatoid Arthritis: Autoimmune conditions frequently overlap with dryness of the skin, mouth, and lips.

Systemic Sclerosis (Scleroderma): Often causes tightening of the skin and severe xerostomia (dry mouth).

Sjögren's Foundation
+3"
November 8, 2026 at 3:32 PM
Nkarta and CRISPR Therapeutics both posted zero-CRS, zero-neurotoxicity Phase 1 data in myositis and scleroderma, Delix raised $100M for DLX-001, and Lilly unblinded ATTAIN-OSA.
https://openbionews.com/analysis/ai-in-bio-weekly-review-2026-11-03-to-09/
AI in Bio Weekly Review: Nkarta & CRISPR
The seven-day window spanning November 3–9, 2026 delivered watershed clinical validation for allogeneic cell therapy in rheumatology, computational neuroplasticity capital formation, and frontier proteomic foundation models: Nkarta and CRISPR Therapeutics unveiled transformative Phase 1 data in myos
openbionews.com
November 11, 2026 at 3:00 AM
Catch our new Substack post on #Scleroderma and the fight for access to biologic medications in #Ontario for severe scleroderma. Featuring the Scleroderma Society of Ontario (SSO).

Join the fight! 🎗️

#sclerodermaawareness #sclerodermamedication

freedomtoknowwellness.substack.com/p/scleroderm...
Scleroderma: The Fight for Medication Coverage in Ontario
Protesting for OHIP coverage of Rituximab and Tocilizumab for people living with severe scleroderma - November 4th & 5th at Queens Park
freedomtoknowwellness.substack.com
November 4, 2026 at 8:06 PM
#ALLO Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease

https://www.stocktitan.net/news/ALLO/allogene-therapeutics-reports-first-clinical-data-from-phase-1-b4hlej4fy6sb.html?utm_source=stocktitan-bluesky&utm_medium=social
Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease
Allogene Therapeutics (ALLO) reported preliminary Phase 1 RESOLUTION results for ALLO-329, showing skin-score improvements in eight of 10 skin-predominant scleroderma patients. These patients achieved and maintained at least a five-point improvement in modified Rodnan skin score, a measure of skin involvement. Nine of 10 remained off background immunosuppressive therapy.At the September 21, 2026 cutoff, 18 patients had completed the 28-day dose-limiting toxicity assessment. None had dose-limiting toxicity, specified neurological or immune syndromes, graft-versus-host disease, or severe cytokine release syndrome. All had treatment-emergent adverse events; three had Grade 3 or higher events. Clinical activity occurred across conditioning approaches, including without chemotherapy to reduce immune cells. Dose escalation continues to inform Phase 2 regimen selection; Allogene plans the next data readout for 2027.
www.stocktitan.net
November 9, 2026 at 1:00 PM
Our study analyzing the T cell landscape in Scleroderma and Lupus patients is now available at the JI. academic.oup.com/jimmunol/art...
The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity
Abstract. T cells in patients with chronic autoimmunity show features of dysfunction. However, the functionally defined T cell subsets that are affected by
academic.oup.com
November 5, 2026 at 5:29 PM
Comparative molecular analysis of histopathologic subtypes reveals shared epithelial remodeling yet distinct fibroblast programs in scleroderma lung disease https://www.biorxiv.org/content/10.64898/2026.11.03.763791v1
November 4, 2026 at 11:31 AM
Comparative molecular analysis of histopathologic subtypes reveals shared epithelial remodeling yet distinct fibroblast programs in scleroderma lung disease https://www.biorxiv.org/content/10.64898/2026.11.03.763791v1
November 4, 2026 at 11:31 AM
Ooh MCTD. You got the grab bag! The sample pack! A little taste of everything awful! 🫂

I was sure I had gonna end up diagnosed with MCTD or scleroderma. But I have just few enough of those symptoms to not meet the criteria.
November 2, 2026 at 4:42 PM
Paul Klee :
La belle jardinière
(The Beautiful Gardener), 1939

Oil and tempera on hessian / burlap
95 × 71 cm | 37 ⅜ × 27 ⅞ in

Zentrum Paul Klee, Bern, Switzerland

Further description in the alt text 👇
November 1, 2026 at 6:11 PM
Honored and grateful that my research on skin fibrosis in #scleroderma was selected for an oral presentation, received APLAR Travel Grant and also nominated for Best Abstract Award at the 28th #APLAR Congress.

Sincere thanks to the #APLAR2026 Scientific Committee for this recognition
#RheumResearch
November 1, 2026 at 9:10 PM
You know nobody ever dies of any disease except cancer in fiction? It's easier to explain than scleroderma. And of course everyone with cancer dies. That is the kind of insight you might find in this twee novel about an alien.
October 31, 2026 at 7:45 PM
This would be a huge breakthrough if it slows or stops scarring. Fingers crossed for more successful testing. #scleroderma #systemicsclerosis

sclerodermanews.com/news/new-ant...
New anti-scarring pill ifetroban safe: Scleroderma Phase 2 trial
An experimental anti-scarring pill called ifetroban was found safe in a Phase 2 trial for scleroderma, though larger studies are needed.
sclerodermanews.com
October 30, 2026 at 5:51 AM
Drs. Peter Morawski and Arpit Mishra at @benaroyaresearch.bsky.social are using ISSAAC-seq to to study #scleroderma. This tool allows them to see what the cells are currently doing and what they're primed to do next by measuring gene expression and chromatin accessibility: https://bit.ly/4iLRPWy
October 29, 2026 at 9:45 PM
Cats sitting on the heating grate or in hot laundry are the best indicator of whether I will have a Reynauds day(stay inside with mitts nearby), or the chance to get outside without blue and white fingers and toes.
#chronicillness
#Reynauds
#ThatColdIndoorSeasonIsComing
#Scleroderma
#Migraines
October 28, 2026 at 1:57 PM
Parasitic bolete (Pseudoboletus parasiticus) is a mushroom found parasitizing earthballs (Scleroderma citrinum) here in the eastern U.S. #Mushrooms #FungiFriends
October 25, 2026 at 12:45 AM
Your support brings Garvan researchers closer to finding the causes of autoimmune diseases like scleroderma.

👉Donate today: https://ow.ly/nrlu50ZZWj6

#AutoimmuneDisease #MedicalResearch #SclerodermaAwareness #GarvanInstitute
October 25, 2026 at 8:00 PM
Sorry you had to deal with this.

My late Mom had several chronic illnesses, including the scleroderma that ended her life. But she was capable of walking from a parking spot to a store, and more than once some ass criticized her for using a disabled spot, despite her placard. Still pisses me off.
October 25, 2026 at 1:33 AM
Honestly, Dell looks more like she suffers from scleroderma.
October 23, 2026 at 9:20 PM
Living Well with Lupus: Tips for People with Lupus.
For me it´s extra hard, besides the #SLE I also have #Scleroderma, #SecondaryRaynauds, #Asthma, #Osteoporosis, #MECFS & #ChronicUnderweight.
😱😱😱
I drew the a$$ card, as we Germans say.
www.lupus.org/resources/li...
@lupus.org
October 25, 2026 at 8:12 AM
My mom has Scleroderma and her hands are so messed up
October 22, 2026 at 8:20 PM